Showing results (1321-1330 of 1,451) with videos related to

Sort By:
Pageof 146
Schizophrenia Research|September 1, 2019
Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter studyNakao Iwata, Jun Ishigooka, Won-Hyoung Kim, et al.
Schizophrenia Research|December 16, 2018
Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospitalEric D Achtyes, Dror Ben-Zeev, Zhehui Luo, et al.
Schizophrenia Research|December 12, 2023
The schizophrenia syndrome, circa 2024: What we know and how that informs its natureRajiv Tandon, Henry Nasrallah, Schahram Akbarian, et al.
Obesity (Silver Spring, Md.)|May 30, 2025
Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity SocietyDariush Mozaffarian, Monica Agarwal, Monica Aggarwal, et al.
Obesity Pillars|June 8, 2026
Erratum: Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity SocietyDariush Mozaffarian, Monica Agarwal, Monica Aggarwal, et al.
JMIR Mental Health|July 29, 2016
mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital DischargeDror Ben-Zeev, Emily A Scherer, Jennifer D Gottlieb, et al.
Annals of Surgical Oncology|May 29, 2015
Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologistsElizabeth H Baldini, Walter Bosch, John M Kane, et al.
Schizophrenia Bulletin|September 27, 2015
Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum DisordersJoey W Trampush, Todd Lencz, Pamela DeRosse, et al.
JAMA Psychiatry|October 17, 2014
Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP studyChristoph U Correll, Delbert G Robinson, Nina R Schooler, et al.
Obesity Pillars|June 8, 2026
Corrigendum to "Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society [Obesity Pillars 15 (2025) 100181]Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, et al.
Pageof 146